Retinitis pigmentosa (RP) is a progressive genetic disorder affecting the retina's light-sensitive cells, called photoreceptors. Night vision deteriorates first, followed by peripheral vision loss, potentially leading to blindness over time. The genetic mutations disrupting retinal cell function prevent visual signals from reaching the brain properly.
While a permanent cure remains elusive, modern treatment approaches in Turkey can slow disease progression significantly. Gene therapy, stem cell research, and vitamin supplementation (particularly vitamins A and E) show promise in preserving remaining vision. Many patients report stable or improved visual function when interventions begin early, though results vary based on disease stage and individual genetics.
Turkish ophthalmology clinics offer comprehensive diagnostic protocols and personalized therapy plans combining multiple modalities. Specialists here focus on slowing degeneration rather than false promises of complete restoration, which aligns with current international medical evidence.
Risks and Side Effects
Allergic reactions to medications or contrast agents used during diagnostic imaging can occur, though rarely severe. Eye inflammation may develop post-treatment, managed with topical corticosteroids. Gene therapy carries theoretical risks of immune response, though clinical trials have shown favorable safety profiles so far.
Infection at injection sites (if intravitreal procedures are used) remains a possibility, typically preventable through sterile technique. Some patients experience temporary discomfort or floaters following treatment, which usually resolve within weeks.
